Kidswell Bio Statistics

Total Valuation

Kidswell Bio has a market cap or net worth of JPY 12.24 billion. The enterprise value is 11.08 billion.

Market Cap	12.24B
Enterprise Value	11.08B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Kidswell Bio has 43.88 million shares outstanding. The number of shares has increased by 36.32% in one year.

Current Share Class	43.88M
Shares Outstanding	43.88M
Shares Change (YoY)	+36.32%
Shares Change (QoQ)	+3.09%
Owned by Insiders (%)	6.34%
Owned by Institutions (%)	-13.47%
Float	28.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	27.09
PS Ratio	2.41
PB Ratio	8.69
P/TBV Ratio	8.69
P/FCF Ratio	13.16
P/OCF Ratio	13.08
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-527.85
EV / Sales	2.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	11.92

Financial Position

The company has a current ratio of 1.55, with a Debt / Equity ratio of 1.30.

Current Ratio	1.55
Quick Ratio	1.00
Debt / Equity	1.30
Debt / EBITDA	n/a
Debt / FCF	1.98
Interest Coverage	0.67

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	1.04%
Revenue Per Employee	133.74M
Profits Per Employee	-552,632
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Kidswell Bio has paid 94.00 million in taxes.

Income Tax	94.00M
Effective Tax Rate	128.77%

Stock Price Statistics

The stock price has increased by +87.23% in the last 52 weeks. The beta is 0.93, so Kidswell Bio's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	+87.23%
50-Day Moving Average	217.54
200-Day Moving Average	143.29
Relative Strength Index (RSI)	46.23
Average Volume (20 Days)	7,550,215

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kidswell Bio had revenue of JPY 5.08 billion and -21.00 million in losses. Loss per share was -0.52.

Revenue	5.08B
Gross Profit	1.43B
Operating Income	28.00M
Pretax Income	73.00M
Net Income	-21.00M
EBITDA	n/a
EBIT	28.00M
Loss Per Share	-0.52

Full Income Statement

Balance Sheet

The company has 3.00 billion in cash and 1.84 billion in debt, giving a net cash position of 1.16 billion or 26.39 per share.

Cash & Cash Equivalents	3.00B
Total Debt	1.84B
Net Cash	1.16B
Net Cash Per Share	26.39
Equity (Book Value)	1.41B
Book Value Per Share	32.11
Working Capital	2.38B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 936.00 million and capital expenditures -6.00 million, giving a free cash flow of 930.00 million.

Operating Cash Flow	936.00M
Capital Expenditures	-6.00M
Free Cash Flow	930.00M
FCF Per Share	21.19

Full Cash Flow Statement

Margins

Gross margin is 28.20%, with operating and profit margins of 0.55% and -0.41%.

Gross Margin	28.20%
Operating Margin	0.55%
Pretax Margin	1.44%
Profit Margin	-0.41%
EBITDA Margin	n/a
EBIT Margin	0.55%
FCF Margin	18.30%

Dividends & Yields

Kidswell Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-36.32%
Shareholder Yield	n/a
Earnings Yield	-0.17%
FCF Yield	7.60%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 27, 2018. It was a forward split with a ratio of 2.

Last Split Date	Jun 27, 2018
Split Type	Forward
Split Ratio	2

Scores

Kidswell Bio has an Altman Z-Score of -0.86 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.86
Piotroski F-Score	2